Is Supernus Pharmaceuticals (SUPN) Still Attractive After Strong Multi-Year Share Price Gains [Yahoo! Finance]
Supernus Pharmaceuticals, Inc. (SUPN)
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.supernus.com
Company Research
Source: Yahoo! Finance
This breakdown is designed to help you frame that question clearly before you make any moves. Over the short and medium term, the stock has logged returns of 3.1% over 7 days, 8.7% over 30 days, 3.6% year to date, 34.6% over 1 year, 32.5% over 3 years and 81.5% over 5 years. These figures naturally raise questions about what is already priced in. Recent news coverage around Supernus has focused on its position within the US pharmaceuticals and biotech space, including ongoing interest in its existing treatment portfolio and pipeline updates that investors watch closely. This context helps frame whether the current price reflects changing expectations around its product mix or just broader sentiment toward the sector. On our framework of 6 valuation checks, Supernus earns a valuation score of 4 . This indicates it screens as undervalued on four of those measures. Next, we will walk through the key valuation methods behind that score before finishing with a different way to think
Show less
Read more
Impact Snapshot
Event Time:
SUPN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SUPN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SUPN alerts
High impacting Supernus Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
SUPN
News
- 3 Low-Volatility Stocks We're Skeptical Of [Yahoo! Finance]Yahoo! Finance
- Supernus Pharmaceuticals (NASDAQ:SUPN) had its price target raised by analysts at Stifel Nicolaus from $50.00 to $55.00. They now have a "hold" rating on the stock.MarketBeat
- Strong Results Lifted Supernus Pharmaceuticals (SUPN) in Q3 [Yahoo! Finance]Yahoo! Finance
- Supernus Stock Is Up 31% This Past Year but Still 20% Below 2018 Highs as One Fund Scales Back [Yahoo! Finance]Yahoo! Finance
- Supernus Pharmaceuticals (NASDAQ:SUPN) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
SUPN
Earnings
- 11/4/25 - Miss
SUPN
Sec Filings
- 1/12/26 - Form 4
- 12/22/25 - Form 4
- 12/19/25 - Form 144
- SUPN's page on the SEC website